UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2021

NEXT STORY
Revolo Biotherapeutics to Present at Stifel 2021 Virtual Healthcare Conference
PREV STORY
iBio Urges Shareholders to Vote “FOR” All Proposals Ahead of its Upcoming Annual Meeting to be Held on December 9
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Clover Health Expands Management Team, Appointing Prabhdeep Singh as Chief Growth Officer and Justin Joseph as Chief Strategy & Development Officer

author_avatar
NASDAQ Market News

Levitee Clinics and Levitee Pharmacies Provide Insight on Integrated Acquisition Strategy for its Addiction and Pain Services

author_avatar
NASDAQ Market News

Molecular Templates, Inc. Announces Dosing of First Subject in Phase I Study of TAK-169 in Relapsed/Refractory Multiple Myeloma

author_avatar
NASDAQ Market News